News

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...
In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. A federal jury in Delaware ...
By Blake Brittain (Reuters) -A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for engaging in anticompetitive behavior to ...
Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws ...
Led by positive momentum for shares of Cisco and Amgen, the Dow Jones Industrial Average is climbing Thursday afternoon. Supported by world-class markets data from Dow Jones and FactSet ...
Luton, Bedfordshire, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) -- The global medical bioreactor market is valued at approximately $4.1 billion in 2024 and is projected to reach around $7.2 ...
Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries. According to the Food ...
Looking at the universe of stocks we cover at Dividend Channel, on 5/16/25, Amgen Inc (Symbol: AMGN), Banco Latinoamericano de Comercio Exterior, S.A. (Symbol: BLX), and Sabra Health Care REIT Inc ...
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent ® (alirocumab) from competing in the market Jury awarded ...